GlaxoSmithKline PLC said Jack Bailey is stepping down as president of U.S. pharmaceuticals at the end of 2019.
Bailey, who has been with GlaxoSmithKline since 2009, will remain as a consultant to the company on the U.S. external environment until 2020.
Meanwhile, the company named Maya Martinez-Davis as Bailey's successor. Martinez-Davis is currently the regional president of EMD Serono Inc.'s Latin America region.
EMD Serono is the Rockland, Mass.-based biopharmaceutical unit of Germany's MERCK KGaA which develops therapies for cancer and neurodegenerative diseases.
Martinez-Davis is set to join GlaxoSmithKline in mid-September and will begin her responsibility as head of the company's U.S. pharmaceuticals business beginning Jan. 1, 2020.